Cited by 1Connective tissue disorders researchNeonatal Health and BiochemistryHemoglobinopathies and Related Disorders

The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.

Investigation of joint hypermobility in individuals with hyperbilirubinemia

Open access
Çınar, Muhammet, Çakar, Mustafa, Öztürk, Kadir, Çetindağlı, İbrahim, Yılmaz, Sedat, Dinç, Ayhan·2019·European Journal of Rheumatology

Abstract

Abstract Objective: Benign joint hypermobility syndrome refers to hypermobile individuals with musculoskeletal symptoms in the absence of any systemic rheumatic disease; its prevalence is approximately 0.5%. In animal studies, bilirubin has been shown to reduce fibrosis induced by bleomycin. It has been suggested that bilirubin leads to hypermobility that affects the structure or function of collagen. In addition, our observation is that hypermobility occurs more often in patients with indirect hyperbilirubinemia. In this study, we aimed to evaluate hypermobility in patients with indirect hyperbilirubinemia. Material and Methods: We recruited 120 consecutive patients with indirect hyperbilirubinemia from a tertiary gastroenterology outpatient clinic and examined them for hypermobility. Hypermobility was evaluated using the Beighton criteria, and other relevant clinical findings were recorded. In addition, a group of healthy individuals (n=107) without hyperbilirubinemia were included as controls. Results: The mean ages of the patients and controls were 33.4±12.9 and 36.2±11.2 years, respectively (p=0.09). In total, 100 (83%) patients and 78 (73%) controls were male (p=0.075). The mean indirect bilirubin levels were 1.44±0.66 mg/dL in the patient group and 0.37±0.18 mg/dL in the control group. Based on the Beighton score, 23 patients (19.2%) in the patient group and 3 (2.8%) individuals in the control group had joint hypermobility. The difference between the groups was statistically significant (p<0.001). Conclusion: According to the results of our study, findings of joint hypermobility are more frequent in patients with indirect hyperbilirubinemia than in controls.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5152/eurjrheum.2016.16051

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

Sorted by citations

See all 1

Metadata

Authors
Çınar, M., Çakar, M., Öztürk, K., Çetindağlı, İ., Yılmaz, S., & Dinç, A.
Affiliations
Gülhane Eğitim ve Araştırma Hastanesi (TR)
Venue
European Journal of Rheumatology
Published
2019-09-03
Volume
4
Issue
1
Pages
36-39
ISSN
  • 2147-9720 (ISSN-L)
  • 2148-4279
OpenAlex
W2593437759
Cited by
1
References
22
Citations by year
2022: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • European Journal of Rheumatology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
joint hypermobility, benign joint hypermobility syndrome, unconjugated hyperbilirubinemia, bilirubin, Beighton score, collagen, fibrosis, musculoskeletal symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigation of joint hypermobility in individuals with hyperbilirubinemia. https://app.cochat.ai/papers/10.5152/eurjrheum.2016.16051
The paper
Çınar, M., Çakar, M., Öztürk, K., Çetindağlı, İ., Yılmaz, S., & Dinç, A. (2019). Investigation of joint hypermobility in individuals with hyperbilirubinemia. European Journal of Rheumatology. https://doi.org/10.5152/eurjrheum.2016.16051